AstraZeneca PLC (AZN)
206.56
+1.62
(+0.79%)
USD |
NYSE |
Feb 24, 16:00
206.56
0.00 (0.00%)
After-Hours: 16:14
AstraZeneca Market Cap : 320.23B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 118.63B |
| Mereo BioPharma Group Plc | 63.06M |
| Regeneron Pharmaceuticals, Inc. | 81.60B |
| Biodexa Pharmaceuticals Plc | 0.9395M |
| Bicycle Therapeutics Plc | 389.85M |
Market Cap Related Metrics
| PE Ratio | 63.00 |
| PS Ratio | 10.97 |
| PEG Ratio | 1.376 |
| Price to Book Value | 6.979 |
| Price to Free Cash Flow | 71.84 |
| Price | 206.56 |
| Earnings Yield | 1.59% |
| PEGY Ratio | 1.331 |
| Operating PE Ratio | 47.35 |